22 May 2013
Keywords: Vernalis, Servier, Oncology collaboration
Article | 17 January 2012
UK drug developer Vernalis (LSE: VER) and independent French pharma company Laboratories Servier have entered into a new three-year joint ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 January 2012
18 January 2012
16 January 2012
© 2013 thepharmaletter.com